Discriminative Ability of Elixhauser's Comorbidity Measure is Superior to Other Comorbidity Scores for Inpatient Adverse Outcomes After Total Hip Arthroplasty
Ondeck NT, Bohl DD, Bovonratwet P, McLynn RP, Cui JJ, Grauer JN. Discriminative Ability of Elixhauser's Comorbidity Measure is Superior to Other Comorbidity Scores for Inpatient Adverse Outcomes After Total Hip Arthroplasty. The Journal Of Arthroplasty 2017, 33: 250-257. PMID: 28927567, DOI: 10.1016/j.arth.2017.08.032.Peer-Reviewed Original ResearchConceptsElixhauser comorbidity measuresCharlson Comorbidity IndexTotal hip arthroplastyAdverse outcomesComorbidity measuresComorbidity indexHip arthroplastyDiscriminative abilityBody mass indexNational Inpatient SampleLength of stayAdverse patient outcomesComorbidity scoreHospital stayPerioperative courseFrailty indexMass indexComplication measuresPatient's probabilityInpatient SamplePatient outcomesDemographic factors ageHigh riskOptimize outcomesAdmission center